Dimensional Fund Advisors LP Acadia Pharmaceuticals Inc Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,798,134 shares of ACAD stock, worth $67.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,798,134

Previous 2,395,600 16.8%

Holding current value

$67.2 Million

Previous $51.7 Million 15.56%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$20.88 - $26.57 $8.4 Million - $10.7 Million	402,534 Added 16.8%	2,798,134 $59.7 Million
Q2 2025 Aug 12, 2025	BUY	$14.1 - $22.95 $10.4 Million - $17 Million	740,230 Added 44.72%	2,395,600 $51.7 Million
Q1 2025 May 13, 2025	BUY	$16.61 - $20.29 $9.44 Million - $11.5 Million	568,530 Added 52.31%	1,655,370 $27.5 Million
Q4 2024 Feb 13, 2025	BUY	$14.29 - $18.76 $3.47 Million - $4.56 Million	243,082 Added 28.81%	1,086,840 $19.9 Million
Q3 2024 Nov 07, 2024	BUY	$15.14 - $19.14 $2.95 Million - $3.72 Million	194,608 Added 29.98%	843,758 $13 Million

Q2 2024 Aug 09, 2024	BUY	$14.62 - $18.42 $9.49 Million - $12 Million	649,150 New	649,150 $10.5 Million
Q4 2023 Feb 07, 2024	SELL	$20.78 - $31.77 $1.18 Million - $1.8 Million	-56,583 Reduced 60.62%	36,754 $1.15 Million
Q3 2023 Nov 09, 2023	SELL	$20.84 - $33.47 $187,643 - $301,363	-9,004 Reduced 8.8%	93,337 $1.95 Million
Q2 2023 Aug 09, 2023	SELL	$17.8 - $25.65 $496,620 - $715,635	-27,900 Reduced 21.42%	102,341 $2.45 Million
Q1 2023 May 12, 2023	SELL	$16.32 - $20.92 $3.04 Million - $3.9 Million	-186,223 Reduced 58.84%	130,241 $2.45 Million
Q4 2022 Feb 09, 2023	SELL	$14.2 - $18.63 $567,304 - $744,287	-39,951 Reduced 11.21%	316,464 $5.04 Million
Q3 2022 Nov 10, 2022	SELL	$14.11 - $18.27 $1.93 Million - $2.49 Million	-136,513 Reduced 27.69%	356,415 $5.83 Million
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $1.93 Million - $4.04 Million	-148,295 Reduced 23.13%	492,928 $6.95 Million
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $398,467 - $523,297	-19,029 Reduced 2.88%	641,223 $15.5 Million
Q4 2021 Feb 09, 2022	BUY	$16.79 - $27.09 $6.18 Million - $9.98 Million	368,365 Added 126.2%	660,252 $15.4 Million
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $222,640 - $349,479	-14,109 Reduced 4.61%	291,887 $4.85 Million
Q2 2021 Aug 12, 2021	SELL	$19.4 - $27.42 $908,327 - $1.28 Million	-46,821 Reduced 13.27%	305,996 $7.46 Million
Q1 2021 May 14, 2021	BUY	$25.02 - $54.99 $392,063 - $861,693	15,670 Added 4.65%	352,817 $9.1 Million
Q4 2020 Feb 25, 2021	BUY	$41.04 - $56.79 $13.8 Million - $19.1 Million	337,147 New	337,147 $18 Million

Others Institutions Holding ACAD

# of Institutions

373

Shares Held

162M

Call Options Held

1.46M

Put Options Held

1.09M

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.89B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Acadia Pharmaceuticals Inc Transaction History